RhumbLine Advisers
CLMT icon

RhumbLine Advisers’s Calumet Specialty Products CLMT Stock Holding History

RhumbLine Advisers’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17M Buy
87,953
+2,897
+3% +$97.4K ﹤0.01% 1696
2026
Q1 		$3.05M Buy
85,056
+727
+0.9% +$18.8K ﹤0.01% 1642
2025
Q4 		$1.68M Sell
84,329
-14,493
-15% -$279K ﹤0.01% 1965
2025
Q3 		$1.8M Sell
98,822
-3,338
-3% -$54.9K ﹤0.01% 1975
2025
Q2 		$1.61M Buy
+102,160
New +$1.3M ﹤0.01% 2003

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RhumbLine Advisers's CLMT Position: Q2 2026 in Review

RhumbLine Advisers increased its Calumet Specialty Products (CLMT) stake by 3.4% in Q2 2026, buying an estimated $97.4K and bringing the position to 87,953 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

RhumbLine Advisers first reported a position in CLMT in Q2 2025 and has held it in 5 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • RhumbLine Advisers held 87,953 shares of Calumet Specialty Products worth $3.17M as of Q2 2026.
  • RhumbLine Advisers bought 2,897 Calumet Specialty Products shares in Q2 2026, an estimated $97.4K.
  • Calumet Specialty Products made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1696 holding.
  • RhumbLine Advisers first reported a position in Calumet Specialty Products in Q2 2025 and has held it in 5 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.